A new day for myeloid
genomic profiling with NGS

Go from specimen to report in a single day

Myeloid Testing shouldn't be so difficult

While myeloid molecular testing can be complex and laborious with single-gene assays relying on multiple technologies like Sanger sequencing, FISH and qPCR, the Oncomine Myeloid Assay GX simplifies the biggest challenges, including extended wait times for results.


Oncomine Myeloid Assay GX

Gene Targets Coverage Time Workflow Reporting
New call-to-action New call-to-action Click me New call-to-action New call-to-action
DNA and RNA profiling with one assay covering all key mutations

Curated gene content associated with major myeloid disorders

Rapid turnaround time – get results for all biomarkers in a single day

Automated workflow with only 10 min. of hands-on time required

Integrated reporting with variants linked to relevant evidence


Profile All Key Myeloid Targets With A Single Assay

Simultaneously interrogate DNA mutations and RNA fusion transcripts covering all major myeloid disorders: AML, MPN, MDS, CMML, and JMML.

With a single assay, you can profile key targets such as FLT3, TP53, NPM1, IDH1/2, BCR-ABL and PML-RARA, along with many other carefully curated biomarkers. 

See Complete Gene List



Expression Genes


Full Genes


Hotspot Genes


Fusion Drivers


Fusion Isotypes

On-Demand Webinar

A new day for myeloid genomic profiling: How NGS advancements are providing deeper insight with faster time to results

In this webinar we'll showcase the latest advancements in myeloid genomic profiling: The Ion Torrent Oncomine Myeloid Assay GX.

Learn how this solution addresses key challenges in myeloid molecular testing and see recent data from the University of Pennsylvania.




Dr. Kojo Elenitoba-Johnson
Peter C. Nowell, M.D., Professor. University  of Pennsylvania Perelman School of Medicine

Dr. Andy Felton
Vice President of Product Management, Clinical Next Generation Sequencing, Thermo Fisher Scientific






1-Day Genomic Profiling For Myeloid Malignancy Research 

With the Ion Torrent Oncomine Myeloid Assay GX on the Ion Torrent Genexus System, you can get a comprehensive myeloid mutational profile from a single next-generation sequencing (NGS) run and results in just one day.

A highly integrated workflow lets you go from specimen to report with only 10 minutes of hands-on time and two user touch points*. It’s never been easier to implement myeloid NGS testing in your lab.



Automate your workflow from specimen to report

Start with any common myeloid specimen type, including whole blood, bone marrow, or peripheral blood leukocytes. From there, the Genexus System integrates and automates nucleic acid extraction, purification, quantitation, library preparation, sequencing, and analysis reporting within a single software ecosystem. 


All Common Species

Whole Blood

Peripheral Blood Leukocytes (PBLs)

Bone Marrow


Automated Workflow

Nucleic acid extraction and quantification

Library preparation


Reporting & analysis


Annotated Variant Report

Biomarkers linked to relevant evidence from public data sources



Flexible Sample Batching

The solution lets you process samples as they come in—even just one. Sequence 1-8 myeloid samples per run. The reagents are stable on the instrument for up to two weeks, giving you the flexibility to process additional samples as needed.

Clear And Concise Reports

Ion Torrent Oncomine Reporter is a curated knowledgebase and reporting software that links biomarkers to relevant evidence and enables custom reporting. These tools help simplify the bioinformatics workflow and enable you to focus on finding the biological meaning of your data.

See Sample Report







On-Demand Presentation

Advances in NGS automation accelerates time to results for research in myeloid and comprehensive genomic profiling

In this workshop, speakers will discuss their perspective and experience with new automated solutions for the Ion Torrent Oncomine Myeloid Assay GX, a revolutionary approach to myeloid profiling that enables specimen-to-report automation in a single day, and Ion Torrent Oncomine Comprehensive Assay Plus, an end-to-end research solution that distills hundreds of genes into a report in as little as three days.




Dr. Yi Ding, MD, PhD.
Geisinger Medical laboratories

Dr. Jon Sherlock, PhD.
Thermo Fisher Scientific

Additional Resources

Book a demo or request a quote

Are you ready to speak to a representative?



For Research Use Only.  Not for use in diagnostic procedures.  *Specimen-to-report workflow will be available after the Ion Torrent Genexus Purification System and integrated reporting capabilities are added in 2021 with the Genexus 6.4 software upgrade.